BioCryst Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Good afternoon. Thank you for joining us at our annual health care conference. I'm Brian Cheng. I'm the senior biotech analyst here at Cantor.
Joining us today is the full team, management team from BioCryst. With us, we have Jon Stonehouse, President and CEO; Anthony Doyle; Charlie; Bill; John; and Helen.
So maybe Jon to get us started, let's talk about your story and also the pipeline that you're working on. Can you just spend a few minutes to give us a quick highlight of your company and the work that you're doing so far? And then we'll jump right back into a Q&A.
Sure. Absolutely. Brian, first, thanks for inviting us to the Cantor conference. It's fantastic to have you as an analyst. We've known Brian for a while, all the way back to another bank that I won't name the name. But you've always been known for doing extremely thorough work. And his recent survey, I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |